Suppr超能文献

The plasma protein binding of metoclopramide in health and renal disease.

作者信息

Webb D, Buss D C, Fifield R, Bateman D N, Routledge P A

出版信息

Br J Clin Pharmacol. 1986 Mar;21(3):334-6. doi: 10.1111/j.1365-2125.1986.tb05201.x.

Abstract

The plasma protein binding of metoclopramide was measured after addition of the drug (60 ng ml-1) to plasma from 18 patients with renal disease and 18 age and sex matched healthy individuals. The mean free fraction in renal disease (0.59 range 0.41-0.71) was not significantly different from controls (mean 0.6 range 0.56-0.69). In both groups the binding ratio of metoclopramide was significantly related to plasma alpha 1-acid glycoprotein (AAG) concentration but not to albumin or plasma non-esterified fatty acids concentration. Metoclopramide bound to human serum albumin (HSA) to a limited extent and to human AAG to a greater extent indicating that AAG is the major binding protein for the drug in plasma.

摘要

相似文献

1
The plasma protein binding of metoclopramide in health and renal disease.
Br J Clin Pharmacol. 1986 Mar;21(3):334-6. doi: 10.1111/j.1365-2125.1986.tb05201.x.
2
Diazepam and lidocaine plasma protein binding in renal disease.
Clin Pharmacol Ther. 1982 Mar;31(3):350-7. doi: 10.1038/clpt.1982.45.
3
Characteristics of serum protein binding of felodipine.
Res Commun Mol Pathol Pharmacol. 1996 Oct;94(1):73-88.
4
Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
Br J Clin Pharmacol. 1990 Jan;29(1):9-18. doi: 10.1111/j.1365-2125.1990.tb03596.x.
6
Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
Biopharm Drug Dispos. 1996 Dec;17(9):739-51. doi: 10.1002/(SICI)1099-081X(199612)17:9<739::AID-BDD987>3.0.CO;2-0.
7
Protein binding of nifedipine.
J Pharm Pharmacol. 1986 May;38(5):399-400. doi: 10.1111/j.2042-7158.1986.tb04598.x.
9
Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
Br J Clin Pharmacol. 1984 Oct;18(4):487-93. doi: 10.1111/j.1365-2125.1984.tb02496.x.
10
Serum binding of indapamide in health and disease: primary role of alpha 1-acid glycoprotein.
J Clin Pharmacol. 1988 May;28(5):458-62. doi: 10.1002/j.1552-4604.1988.tb05760.x.

引用本文的文献

2
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
Clin Pharmacokinet. 2017 Dec;56(12):1525-1541. doi: 10.1007/s40262-017-0538-0.
3
The plasma protein binding of basic drugs.
Br J Clin Pharmacol. 1986 Nov;22(5):499-506. doi: 10.1111/j.1365-2125.1986.tb02927.x.
4
Pharmacokinetics of high-dose metoclopramide in cancer patients.
Clin Pharmacokinet. 1986 Nov-Dec;11(6):415-24. doi: 10.2165/00003088-198611060-00001.
5
Population analysis of the pharmacokinetic variability of high-dose metoclopramide in cancer patients.
Clin Pharmacokinet. 1988 Jan;14(1):52-63. doi: 10.2165/00003088-198814010-00004.
6
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).
Clin Pharmacokinet. 1990 Sep;19(3):218-29. doi: 10.2165/00003088-199019030-00005.
7
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.
8
Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis.
Eur J Clin Pharmacol. 1991;40(4):423-5. doi: 10.1007/BF00265857.
9
Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
Br J Clin Pharmacol. 1991 Feb;31(2):185-7. doi: 10.1111/j.1365-2125.1991.tb05511.x.

本文引用的文献

1
THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA.
Clin Chim Acta. 1964 Feb;9:122-5. doi: 10.1016/0009-8981(64)90004-x.
2
The pharmacokinetics of metoclopramide in man with observations in the dog.
Br J Clin Pharmacol. 1980 Apr;9(4):371-7. doi: 10.1111/j.1365-2125.1980.tb01064.x.
3
Lidocaine plasma protein binding.
Clin Pharmacol Ther. 1980 Mar;27(3):347-51. doi: 10.1038/clpt.1980.46.
4
The pharmacokinetics of single doses of metoclopramide in renal failure.
Eur J Clin Pharmacol. 1981;19(6):437-41. doi: 10.1007/BF00548588.
5
Diazepam and lidocaine plasma protein binding in renal disease.
Clin Pharmacol Ther. 1982 Mar;31(3):350-7. doi: 10.1038/clpt.1982.45.
6
Drug therapy in renal failure.
Annu Rev Pharmacol Toxicol. 1980;20:45-54. doi: 10.1146/annurev.pa.20.040180.000401.
7
Determinants of the plasma protein binding of theophylline in health.
Br J Clin Pharmacol. 1983 Apr;15(4):399-405. doi: 10.1111/j.1365-2125.1983.tb01521.x.
8
Disease-induced changes in the plasma binding of basic drugs.
Clin Pharmacokinet. 1980 May-Jun;5(3):246-62. doi: 10.2165/00003088-198005030-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验